Tokyo - Delayed Quote JPY

Modalis Therapeutics Corporation (4883.T)

Compare
97.00
-2.00
(-2.02%)
At close: 3:30:00 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.
NameTitlePayExercisedYear Born
Mr. Haruhiko Morita Co-Founder, Chairman, President & CEO -- -- 1969
Mr. Tetsuya Yamagata M.D., Ph.D. Chief Scientific Officer -- -- --

Modalis Therapeutics Corporation

Y’s Building
4th Floor 16-5Nihonbashi-kabuto-cho Chuo-ku
Tokyo, 103-0026
Japan
https://modalistx.com
Sector: 
Healthcare
Full Time Employees: 
37

Description

Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. It is developing therapies for genetic diseases using its proprietary CRISPR-GNDM technology that enables to control gene expressions through modulating the switch (epigenetics of a specific locus. The company has a. joint research agreement with JCR Pharmaceuticals Co., Ltd. to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corporation was founded in 2016 and is headquartered in Tokyo, Japan.

Corporate Governance

Modalis Therapeutics Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 13, 2025 at 6:00 AM UTC

Modalis Therapeutics Corporation Earnings Date

Recent Events

Related Tickers

ASTRAZEN.NS AstraZeneca Pharma India Limited
7,262.80
+0.80%
 
BGM BGM Group Ltd.
9.40
+1.82%
 
GLASF Glass House Brands Inc.
6.07
-0.49%
 
EOLS Evolus, Inc.
14.12
-3.06%